X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3194) 3194
Book Review (551) 551
Publication (274) 274
Magazine Article (12) 12
Conference Proceeding (10) 10
Book Chapter (5) 5
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2957) 2957
humans (2528) 2528
benzhydryl compounds - therapeutic use (1856) 1856
male (1655) 1655
female (1462) 1462
animals (897) 897
middle aged (880) 880
adult (856) 856
pharmacology & pharmacy (795) 795
benzhydryl compounds - pharmacology (669) 669
benzhydryl compounds - adverse effects (621) 621
aged (579) 579
glucosides - therapeutic use (576) 576
treatment outcome (567) 567
diabetes mellitus, type 2 - drug therapy (562) 562
double-blind method (530) 530
modafinil (507) 507
double-blind (486) 486
hypoglycemic agents - therapeutic use (465) 465
benzhydryl compounds - administration & dosage (436) 436
tolterodine tartrate (428) 428
toxicology (421) 421
benzhydryl compounds (420) 420
central nervous system stimulants - therapeutic use (420) 420
rats (403) 403
dose-response relationship, drug (378) 378
bisphenol a (357) 357
muscarinic antagonists - therapeutic use (346) 346
bisphenol-a (339) 339
cresols - therapeutic use (339) 339
sodium-glucose transporter 2 - antagonists & inhibitors (327) 327
type 2 diabetes (314) 314
mice (313) 313
endocrinology & metabolism (311) 311
analysis (304) 304
phenols - toxicity (302) 302
psychiatry (296) 296
adolescent (294) 294
diabetes (294) 294
neurosciences (293) 293
glucose (274) 274
abridged index medicus (263) 263
phenylpropanolamine - therapeutic use (255) 255
drug therapy, combination (254) 254
care and treatment (249) 249
dapagliflozin (243) 243
efficacy (226) 226
drug therapy (222) 222
urinary bladder, overactive - drug therapy (222) 222
overactive bladder (219) 219
phenols (219) 219
urology & nephrology (213) 213
benzhydryl compounds - toxicity (212) 212
glucosides - adverse effects (212) 212
clinical neurology (203) 203
terfenadine (198) 198
medicine, general & internal (195) 195
young adult (184) 184
research (182) 182
safety (182) 182
randomized controlled trials as topic (181) 181
placebo-controlled trial (179) 179
hypoglycemic agents - adverse effects (177) 177
time factors (175) 175
clinical trials as topic (171) 171
narcolepsy (168) 168
clinical trials (167) 167
glucosides - pharmacology (167) 167
tolterodine (163) 163
metformin (160) 160
histamine h1 antagonists - therapeutic use (159) 159
risk factors (159) 159
empagliflozin (156) 156
exposure (155) 155
medicine & public health (155) 155
aged, 80 and over (154) 154
rats, sprague-dawley (154) 154
article (153) 153
benzhydryl compounds - pharmacokinetics (151) 151
central nervous system stimulants - pharmacology (150) 150
diabetes mellitus, type 2 - blood (150) 150
internal medicine (149) 149
sglt2 inhibitor (149) 149
child (148) 148
urinary incontinence (148) 148
diabetes mellitus (144) 144
central nervous system stimulants - adverse effects (143) 143
blood glucose - metabolism (142) 142
dextrose (141) 141
quality of life (139) 139
diabetes mellitus, type 2 - complications (138) 138
quality-of-life (138) 138
urinary incontinence - drug therapy (137) 137
blood glucose - drug effects (134) 134
dosage and administration (133) 133
glucosides - administration & dosage (133) 133
insulin (133) 133
pharmacokinetics (133) 133
muscarinic antagonists - adverse effects (130) 130
inadequate glycemic control (127) 127
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2995) 2995
German (61) 61
Russian (36) 36
Spanish (27) 27
French (25) 25
Japanese (17) 17
Chinese (13) 13
Italian (11) 11
Czech (8) 8
Danish (3) 3
Polish (3) 3
Swedish (3) 3
Bulgarian (2) 2
Dutch (2) 2
Hebrew (2) 2
Hungarian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 22, pp. 2117 - 2128
Journal Article
EUROPEAN UROLOGY, ISSN 0302-2838, 02/2013, Volume 63, Issue 2, pp. 283 - 295
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 323 - 334
Journal Article
Diabetes Care, ISSN 0149-5992, 2014, Volume 37, Issue 7, pp. 1815 - 1823
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article